P183 A systematic review on outcome measures of long-term efficacy in clinical trials concerning Crohn’s disease patients
Laura Janssen(Maastricht University Medical Centre), Rob H. Creemers(Zuyderland Medisch Centrum), A Van Bodegraven(Zuyderland Medisch Centrum)
Cited by 1
Related Papers
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
|Journal of Crohn s and Colitis|2020|71
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
|Clinical Gastroenterology and Hepatology|2022|51
Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study
|Pharmaceutics|2023|17
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
|Journal of Crohn s and Colitis|2022|16